跳至主要内容
临床试验/PACTR201411000912262
PACTR201411000912262尚未招募未知

Sugammadex versus neostigmine for antagonism of rocuronium-induced neuromuscular blockade in cirrhotic patients undergoing liver resection: A controlled randomised study

ational liver institute0 个研究点目标入组 60 人开始时间: 2014年10月19日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Year(s) 至 60 Year(s)(—)
性别
All

入选标准

  • American Society of Anesthesiologists physical status class I-III (Class I in patients with preoperative normal liver functions).
  • Thirty patients categorized as Child classification ¿A¿ with a Model for End-Stage Liver Disease (MELD) score <10. Additional 30 patients with normal preoperative liver functions will serve as controls

排除标准

  • Co-existing neuromuscular disease, body mass index more than 35 kg/m-2, renal impairment, medications known to affect neuromuscular transmission e.g. aminoglycoside antibiotics or magnesium sulphate, bleeding tendency, and intraoperative events e.g. (massive bleeding and hypothermia).

研究者

发起方
ational liver institute

相似试验